Sophia Genetics Sa (SOPH) has released an update.
SOPHiA GENETICS SA celebrated a stellar 2023, investing $400 million in AI for healthcare and establishing SOPHiA DDM™ as a leading platform with 770+ global healthcare institutions. The company achieved a 31% revenue increase to $62.4 million, with a significant 36% reduction in cash burn, while expanding their customer base and partnerships, including with Memorial Sloan Kettering and AstraZeneca. These strides underscore the company’s commitment to operational excellence and strategic growth in the precision medicine industry.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.
